The fellow will be part of the gRED Clinical Pharmacology Department, which is responsible for applying the principles of quantitative pharmacology to enable selection of a safe and effective dose, route and regimen for small molecules and biologics. The Genentech Clinical Pharmacology Fellowship program builds on the synergy between the fellow’s comprehensive Doctor of Pharmacy training and Genentech’s innovation in drug development to prepare the individual for a career in the biotechnology/pharmaceutical industry. The fellowship began Jand ends June 30, 2023. In the role of a Clinical Scientist, the fellow will gain experience in the basic principles of clinical oncology research. The organization is responsible for developing strategies for and executing on First-in-Human, Phase 1, and Proof-of-Concept oncology clinical trials. Genentech's Oncology Early Clinical Development mission is to provide the clinical leadership and skills to successfully develop novel cancer therapies and the means by which to identify the patients who benefit from them. The fellowship begins Jand ends June 30, 2024. Develop understanding of Phase I-II drug development.
Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations.Investigator meetings, scientific congresses, advisory boards, site visits, site staff training) Genentech/Roche) and external meetings (e.g. Create, review and present clinical slides for internal (i.e.
protocol execution, clinical, biomarkers, pharmacokinetics) Serve as a clinical science representative on cross-functional sub-teams (i.e.The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities: GRED's OMNI (Ophthalmology, Metabolism, Neurology, Infectious Disease, Immunology) organization is responsible for developing and executing early development clinical strategies in healthy volunteers and patients to provide data for gRED non-oncology new molecular entities with respect to safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and the utility of biomarkers. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities. This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of clinical research.